ARCO vs. PFE
Compare and contrast key facts about Arcos Dorados Holdings Inc. (ARCO) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ARCO or PFE.
Correlation
The correlation between ARCO and PFE is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ARCO vs. PFE - Performance Comparison
Loading data...
Key characteristics
ARCO:
-0.73
PFE:
-0.50
ARCO:
-0.97
PFE:
-0.54
ARCO:
0.89
PFE:
0.94
ARCO:
-0.39
PFE:
-0.20
ARCO:
-1.14
PFE:
-0.86
ARCO:
23.68%
PFE:
13.36%
ARCO:
36.48%
PFE:
24.13%
ARCO:
-91.66%
PFE:
-58.96%
ARCO:
-64.86%
PFE:
-55.27%
Fundamentals
ARCO:
$1.67B
PFE:
$131.28B
ARCO:
$0.71
PFE:
$1.38
ARCO:
11.17
PFE:
16.73
ARCO:
2.15
PFE:
0.59
ARCO:
0.37
PFE:
2.10
ARCO:
3.33
PFE:
1.45
ARCO:
$3.39B
PFE:
$62.46B
ARCO:
$454.40M
PFE:
$42.09B
ARCO:
$369.91M
PFE:
$16.71B
Returns By Period
In the year-to-date period, ARCO achieves a 9.73% return, which is significantly higher than PFE's -9.84% return. Over the past 10 years, ARCO has outperformed PFE with an annualized return of 5.63%, while PFE has yielded a comparatively lower 0.79% annualized return.
ARCO
9.73%
9.83%
-3.32%
-26.51%
21.66%
5.63%
PFE
-9.84%
7.40%
-8.84%
-12.05%
-3.76%
0.79%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ARCO vs. PFE — Risk-Adjusted Performance Rank
ARCO
PFE
ARCO vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Arcos Dorados Holdings Inc. (ARCO) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
ARCO vs. PFE - Dividend Comparison
ARCO's dividend yield for the trailing twelve months is around 3.03%, less than PFE's 7.36% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARCO Arcos Dorados Holdings Inc. | 3.03% | 3.30% | 1.50% | 1.79% | 0.00% | 2.19% | 1.36% | 1.27% | 0.00% | 0.00% | 0.00% | 4.40% |
PFE Pfizer Inc. | 7.36% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% | 3.34% |
Drawdowns
ARCO vs. PFE - Drawdown Comparison
The maximum ARCO drawdown since its inception was -91.66%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for ARCO and PFE. For additional features, visit the drawdowns tool.
Loading data...
Volatility
ARCO vs. PFE - Volatility Comparison
Arcos Dorados Holdings Inc. (ARCO) and Pfizer Inc. (PFE) have volatilities of 8.80% and 8.61%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
ARCO vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Arcos Dorados Holdings Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ARCO vs. PFE - Profitability Comparison
ARCO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Arcos Dorados Holdings Inc. reported a gross profit of 170.66M and revenue of 1.14B. Therefore, the gross margin over that period was 14.9%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.
ARCO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Arcos Dorados Holdings Inc. reported an operating income of 102.92M and revenue of 1.14B, resulting in an operating margin of 9.0%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.
ARCO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Arcos Dorados Holdings Inc. reported a net income of 58.40M and revenue of 1.14B, resulting in a net margin of 5.1%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.